Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Multiple Myeloma 63 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Burkitt Lymphoma 25 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 11 Lymphoma, Mantle-Cell 7 Leukemia, Biphenotypic, Acute 7 Recurrence 6 Immunoglobulin Light-chain Amyloidosis 6 Vomiting 5 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Large B-Cell, Diffuse 5 Lymphoma 5 Leukemia, Myeloid, Acute 5 Carcinoma, Non-Small-Cell Lung 5 Smoldering Multiple Myeloma 4 Neoplasm Metastasis 4 Nausea 4 Leukemia 4 Hodgkin Disease 4 Breast Neoplasms 4 Blast Crisis 4 Plasmacytoma 3 Ovarian Neoplasms 3 Neoplasms 3 Myelodysplastic Syndromes 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Follicular 3 Lymphoma, B-Cell, Marginal Zone 3 Lung Neoplasms 3 Leukemia, Plasma Cell 3

Interventions

Docetaxel 292 Prednisone 241 enzalutamide 195 Leuprolide 185 Radiotherapy 179 Abiraterone Acetate 170 Magnetic Resonance Spectroscopy 163 bicalutamide 141 Goserelin 138 Androgen Antagonists 121 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 108 Radiosurgery 108 apalutamide 93 abiraterone 83 gallium 68 PSMA-11 81 Specimen Handling 73 darolutamide 67 Surveys and Questionnaires 64 Gonadotropin-Releasing Hormone 63 Triptorelin Pamoate 58 Radiation 57 Biopsy 57 Brachytherapy 54 cabazitaxel 53 Standard of Care 51 Radiotherapy, Intensity-Modulated 51 Zoledronic Acid 50 pembrolizumab 49 luprolide acetate gel depot 49 Flutamide 47

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Prostatic Neoplasms × dexamethasone 21-phosphate × Clear all

NCT02491411 2018-07-12

DEXTER

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase NA Terminated

5 enrolled 5 charts

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡